These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 76475)

  • 41. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
    Aisenberg AC
    N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
    [No Abstract]   [Full Text] [Related]  

  • 42. Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.
    Mann RB; Jaffe ES; Berard CW
    Am J Pathol; 1979 Jan; 94(1):105-92. PubMed ID: 367172
    [No Abstract]   [Full Text] [Related]  

  • 43. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076
    [No Abstract]   [Full Text] [Related]  

  • 44. Antigens specific for human T-lymphocytes detected by xenoantisera to HD-MAR cells: their differential expression on various T-cell lines.
    Rabinowitz R; Weinstock J; Margalioth EJ; Ben-Bassat H; Schlesinger M
    Hum Immunol; 1982 Jun; 4(3):219-28. PubMed ID: 6181032
    [No Abstract]   [Full Text] [Related]  

  • 45. The incidence of B cell leukaemia and lymphopenia in B cell neoplasia in adults: a study using the Kiel classification of non-Hodgkin's lymphoma.
    Cader A; Richardson P; Walsh L; Ling NR; MacLennan IC; Jones EL; Leyland M
    Br J Cancer; 1983 Aug; 48(2):185-93. PubMed ID: 6603860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunofluorometric analyses of membrane bound IgM in individual human lymphoid cells in cases of leukemia and malignant lymphoma.
    Killander D; Johansson B; Haglund S
    Haematol Blood Transfus; 1977; 20():147-56. PubMed ID: 273002
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunologic and morphologic studies of B-cell lymphoma with cutaneous involvement. Report of a case.
    Claudy AL; Schmitt D; Alario A; Touraine JL; Bryon PA; Souteyrand P; Thivolet J
    Clin Immunol Immunopathol; 1977 Sep; 8(2):254-64. PubMed ID: 332425
    [No Abstract]   [Full Text] [Related]  

  • 48. Diagnostic information derived from immunotyping 1000 patients with leukemia and lymphoma.
    Jose DG; Pilkington GR; Wolf MM; Ding JC; Van der Weyden MB; Gan TE; Elliott P; Whiteside M
    Pathology; 1983 Jan; 15(1):53-60. PubMed ID: 6602319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional markers: a new perspective on malignant lymphomas.
    Jaffe ES; Braylan RC; Nanba K; Frank MM; Berard CW
    Cancer Treat Rep; 1977 Sep; 61(6):953-62. PubMed ID: 302739
    [No Abstract]   [Full Text] [Related]  

  • 50. New aspects in the classification of leukemic cell types by Ia alloantigens and complement receptors.
    Wernet P; Schunter F; Wilms K; Waller HD
    Haematol Blood Transfus; 1977; 20():333-9. PubMed ID: 305401
    [No Abstract]   [Full Text] [Related]  

  • 51. Study of human T and B lymphocytes with heterologous antisera. IV. Subpopulations in tonsil and adenoid cell suspensions.
    Brochier J; Samarut C; Bich-Thuy LT; Revillard JP
    Immunology; 1978 Nov; 35(5):827-35. PubMed ID: 309859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell markers in lymphomas and leukemias.
    Bowman WP; Melvin S; Mauer AM
    Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
    [No Abstract]   [Full Text] [Related]  

  • 53. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of a combined rosette-fluorescent test in studies on leukemia cells.
    Stella-Hołowiecka B; Hołowiecki J; Szeruda-Rudzka E; Krawczyk-Kuliś M
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):165-70. PubMed ID: 375866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphocytic lymphoma simulating hairy cell leukemia: a consideration of reliable and unreliable diagnostic features.
    Palutke M; Tabaczka P; Mirchandani I; Goldfarb S
    Cancer; 1981 Nov; 48(9):2047-55. PubMed ID: 6975157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A study of surface markers in non-Hodgkin's lymphoma by using anti-T and anti-B lymphocyte sera.
    Yamanaka N; Ishii Y; Koshiba H; Mikuni C; Ogasawara M; Kikuchi K
    Cancer; 1981 Jan; 47(2):311-8. PubMed ID: 7006795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.
    Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL
    Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759
    [No Abstract]   [Full Text] [Related]  

  • 58. Lymphocyte markers in human leukemias and lymphomas: methodologic remarks.
    Preud'homme JL; Guglielmi P; Labaume S
    Semin Hematol; 1984 Oct; 21(4):296-301. PubMed ID: 6387921
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunological characterization of human chronic lymphatic leukaemia (author's transl)].
    Barboni F; Rovinetti C; Lombardo M; Beltrandi E; Di Marzio A; Tabacchi P; Di Primio R; Geraci L; Battista P; Torlontano G
    Haematologica; 1979 Apr; 64(2):159-72. PubMed ID: 112007
    [No Abstract]   [Full Text] [Related]  

  • 60. Non-Hodgkin lymphomas: cell populations and functional behavior.
    Krueger GR; Samii H; Sesterhenn K; Uhlmann C; Ablashi DV; Fischer R; Wustrow F
    Haematol Blood Transfus; 1977; 20():55-60. PubMed ID: 204551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.